The Meyer Cancer Center will host a seminar featuring Dr. Omar Abdel-Wahab, a leading expert in cancer research, on February 27, 2026, at 12:00 pm. This seminar, part of the center’s Director’s Seminar Series, aims to delve into the complexities of aberrant RNA processing in cancer, highlighting advancements in molecular pharmacology.
Understanding the Seminar Focus
Dr. Abdel-Wahab, who holds the Evnin Family Chair in Molecular Pharmacology and serves as the Chair of the Molecular Pharmacology Program at the Sloan Kettering Institute, will discuss the critical role of RNA processing in cancer development and progression. His work has significant implications for developing targeted therapies aimed at these mechanisms.
In addition to his directorship, Dr. Abdel-Wahab is an attending physician in the Leukemia Service at the Memorial Sloan Kettering Cancer Center and a professor of medicine at Weill Cornell Medical College. His extensive expertise positions him to provide valuable insights into the current research landscape.
Event Details and Participation
The seminar will take place at the Belfer Research Building, located at 413 East 69th Street, 2nd Floor, in New York City. In-person attendance is encouraged, providing an opportunity for attendees to engage directly with Dr. Abdel-Wahab and other researchers in the field. For those unable to attend in person, arrangements for virtual participation via Zoom are available by contacting [email protected].
This seminar promises to be an enlightening experience for those interested in cancer research, particularly in understanding the molecular underpinnings that drive cancer biology. The Meyer Cancer Center invites students, researchers, and healthcare professionals to attend this important event.
For more information about the seminar and to register, please visit the official event page at the Meyer Cancer Center’s website.
